Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co hires own lawyer to head global sales and marketing

Merck & Co selects its top lawyer to head up worldwide sales and marketing arms from the beginning of August 2007

US-based Merck & Co has selected its top lawyer, Kenneth Frazier, to head up its worldwide sales and marketing organisations, which include global human health from the beginning of August 2007.

Frazier takes over from Peter Loescher, who has left Merck to start his new role as CEO of German technology giant, Siemens.

Frazier will report directly to CEO Richard Clark and be responsible for Merckís 30,000 sales and marketing employees in its globally active drugs and vaccines businesses.

As Merck's executive vice-president of general counsel Frazier has helped Merck to navigate the treacherous waters of the ongoing Vioxx (rofecoxib) litigations.

Frazier joined Merck in 1992 as vice-president of general counsel and secretary of Astra Merck, going on to become vice-president of public affairs, assistant general counsel for corporate staff and vice-president of deputy general counsel and senior vice-president of general counsel.

Frazier becomes the highest ranking African-American executive in the pharmaceutical industry to date.

Bruce Kuhlik, who now becomes senior vice-president, takes over from Frazier as general counsel. He will also report directly to Clark and serve as a member of the executive committee which evaluates and makes strategic decisions for the company.

30th July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics